-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on HCA Healthcare, Raises Price Target to $635

Benzinga·02/23/2026 20:32:02
Listen to the news
UBS analyst Andrew Mok maintains HCA Healthcare (NYSE:HCA) with a Buy and raises the price target from $598 to $635.